Investigation of absolute and relative response for three different liquid chromatography/tandem mass spectrometry systems; The impact of ionization and detection saturation

Rapid Communications in Mass Spectrometry

Volumn 26, Issue 12, 2012, Pages 1399-1406

  Nilsson, Lars B ^a   Skansen, Patrik ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALIBRATION; IMPACT IONIZATION; IONS; ISOTOPES; LINEAR REGRESSION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ABSOLUTE RESPONSE; CONCENTRATION RANGES; CONCENTRATION UNITS; LINEAR CALIBRATION CURVE; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MATRIX; PEAKS AREAS; RELATIVE RESPONSE; STABLE ISOTOPE LABELED INTERNAL STANDARDS;

MATRIX ALGEBRA;

EID: 84861310483     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6239     Document Type: Article

References (23)

1. C. G. Enke,. A predictive model for matrix and analyte effects in electrospray ionization of singly-charged ionic analytes. Anal. Chem. 1997, 69, 4885.
2. A. J. Santos-Neto, K. E. Markides, P. J. R. Sjöberg, J. Bergquist, F. M. Lancas,. Capillary column switching restricted-access media liquid chromatography-electrospray ionization-tandem mass spectrometry system for simultaneous and direct analysis of drugs in biofluids. Anal. Chem. 2007, 79, 6359.
3. B. K. Matuszewski, M. L. Constanzer, C. M. Chavez-Eng,. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 1998, 70, 882.
4. B. K. Matuszewski, M. L. Constanzer, C. M. Chavez-Eng,. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019.
5. E. Chambers, D. M. Wagrowski-Diehl, Z. Lu, J. R. Mazzeo,. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 2007, 852, 22.
6. O. A. Ismaiel, M. S. Halquist, M. Y. Elmamly, A. Shalaby, H. T. Karnes,. Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. J. Chromatogr. B 2008, 875, 333.
7. D. Remane, M. R. Meyer, D. K. Wissenbach, H. H. Maurer,. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization. Rapid Commun. Mass Spectrom. 2010, 24, 3103.
8. L. B. Nilsson, G. Eklund,. Direct quantification in bioanalytical LC-MS/MS using internal calibration via analyte/stable isotope ratio. J. Pharm. Biomed. Anal. 2007, 43, 1094
9. D. Wade,. Deuterium isotope effects on noncovalent interactions between molecules. Chem. Biol. Interact. 1999, 117, 191S.
10. Wang, M. Cyronak, E. Yang,. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J. Pharm. Biomed. Anal. 2007, 43, 701.
11. 3H labelled solutes and solvents. J. Chromatogr. A 2006, 1116, 109.
12. E. Stokvis, H. Rosing, J. H. Beijnen,. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun. Mass Spectrom. 2005, 19, 401.
13. 13C labelled intermal standards-A solution to minimize ion suppression effects in liquid chromatography-tandem mass spectrometry analyses of drugs in biological samples. J. Chromatogr. A. 2011, 1218, 9366.
14. X. Zhang, K. D. Oakes, D. Luong, C. D. Metcalfe, M. R. Servos,. Solid-phase microextraction coupled to LC-ESI-MS/MS: Evaluation and correction for matrix-induced ionization suppression/enhancement for pharmaceutical analysis in biological and environmental samples. Anal. Chem. 2011, 83, 6532.
15. G. Liu, Q. C. Ji, M. E. Arnold,. Identifying, evaluating and controlling bioanalytical risks resulting from nonuniform matrix ion suppression/enhancement and nonlinear liquid chromatography-mass spectrometry assay response. Anal. Chem. 2010, 82, 9671.
16. B. K. Matuszewski,. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B 2006, 830, 292.
17. A. K. Hewavitharana,. Matrix matching in liquid chromatography-mass spectrometry with stable isotope labelled internal standards-Is it necessary ? J. Chromatogr. A 2011, 1218, 359.
18. B.-M. Jacobson, A. Olsson, C. Fakt, D. Öhman,. The use of human plasma as matrix for calibration standards in pre-clinical LC-MS/MS methods-A way to reduce animal use. J. Pharm. Biomed. Anal. 2011, 54, 826.
19. Guidance for Industry, Bioanalytical Method Validation, US Food and Drug Administration, 2001. Available:.
20. A. Tan, I. A. Lévesque, I. M. Lévesque, F. Viel, N. Boudreau, A. Lévesque,. Analyte and internal standard cross signal contributions and their impact on quantitation in LC-MS based bioanalysis. J. Chromatogr. B 2011, 879, 1954.
21. D. Walker, J. Brady, D. Dalvie, J. Davis, M. Dowty, J. N. Duncan, A. Nedderman, R. S. Obach, P. Wright,. A holistic strategy for characterizing the safety of metabolites through drug discovery and development. Chem. Res. Toxicol. 2009, 22, 1653.
22. L. Renman, D. Jagner,. Asymmetric distribution of results in calibration curve and standard addition evaluations. Anal. Chim. Acta 1997, 357, 157.
23. F. T. Peters, H. H. Maurer,. Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasma. Anal. Chem. 2007, 79, 4967.